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Figure 1. Graph depicting the effect sizes (95% CI) for pain.
or in combination with other therapies. These data should predicate a
re-evaluation of its overall cost-utility.
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Purpose: Our objective was to collect pilot data on the effect of intra-
articular hyaluronic acid (HA) treatment on the gait variability of knee
osteoarthritis (OA) patients. The degenerative knee changes, pain, and loss
of function associated with knee OA can lead to a less stable walking
pattern, increasing the risk for falling. Gait variability, speciﬁcally high
stride time (StrTM), single support time (SSTM), and base of support (BSup)
variability, has been shown to predict falls, and is associated with mobility
decline and disability. Intra-articular HA knee injections are used to control
pain in knee OA patients; however, evidence on the effect of HA on
spatio-temporal gait performance is limited. We hypothesized that knee
OA patients treated with HA would experience greater reductions in pain
and gait variability than matched controls receiving placebo injections (P).
Methods: Thirty older adults with mild to moderate radiographically diag-
nosed knee OA were equally randomized to receive 3 consecutive weekly
knee injections of 2 ml HA (20 mg of HA) or 1.2 ml P (0.001 mg of
HA). Fast gait characteristics were determined with a 10 metre electronic
walkway (GAITRite System), and clinical outcomes of knee pain, stiffness,
and physical function were assessed using the WOMAC OA Index. Gait
variability was determined by calculating the coeﬃcient of variation (CoV)
for each of StrTM, SSTM, and BSupp. Treatment effects were determined
by comparing baseline outcomes to those three (3m) and six months (6m)
post-treatment, using repeated measures ANCOVA, controlling for baseline
fear of falling.
Results: The participants were [Mx (SD)] 72.44 (6.11) years old and all lived
within the community. The StrTM, SSTM, and BSup CoV of the HA group
remained relatively unchanged throughout the study, while these same
measures of gait variability increased for the P group, with the greatest
increases observed at 6m. However, there were no signiﬁcant differences
between the HA and P groups regarding the CoV for StrTM [Mean difference
(95%CI)] [0.25 (0.70; - 0.20)], SSTM [0.48 (1.35; - 0.39)], or BSup [0.87 (6.77;
- 5.03)]. The HA group experienced greater reduction in WOMAC scores
than the P group, however, there were no signiﬁcant differences between
the HA and P groups regarding the WOMAC subsections of pain [2.27 (4.75;
- 0.22)], stiffness [0.80 (1.78; - 0.18)], and physical function [6.63 (14.35; -
1.10)].
Conclusions: The results of this small sample study demonstrate that
gait variability in knee OA patients was not reduced with intra-articular
HA treatment. However, the trends observed in the results indicate that
when compared to intra-articular P, intra-articular HA may maintain gait
function in knee OA patients by preventing further increases in gait vari-
ability, particularly in StrTM and SSTM variability. Since gait disturbances
are important risk factors for falling, these preliminary results provide
rationale for further investigation in a larger trial assessing the effect of
intra-articular HA on gait variability, and in reducing the risk of falling and
mobility decline in the elder knee OA population.
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A COMPARISON OF THE BENEFITS AND LIMITATIONS OF GUIDANCE BY
ULTRASOUND FOR INTRA-ARTICULAR HYALURONIC ACID INJECTIONS
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MEDIAL PATELLAR APPROACHES
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Purpose: Although guidance for injections conducted by real-time ﬂuoro-
scopic imaging is useful to increase the accuracy rates of intra-articular
(IA) hyaluronic acid (HA) injections for osteoarthritis (OA) of the knee, this
imaging implies a certain dosage of radiation to the patient. Qvistgaard et
al (Osteoarthritis Cartilage. 2001) and Im et al (J Ultrasound Med. 2009)
reported the feasibility of guidance using ultrasound (US) for IA injections
in the knee through lateral and medial patellar approaches, respectively
(Figure 1). This study was designed to compare the accuracy rates and
visual analogue scale (VAS) for the highest subjective severe pain during
an injection by a orthopaedic surgeon who was beginner in the use of US
between the two approaches reported by Qvistgaard et al (Q) and Im et al
(I).
Figure 1
Methods: Eighty patients diagnosed with ‘dry’ knee OA with no clinically
detectable effusion received HA injections through the Q and I approaches.
A volume of 0.5-1 ml of asmospheric air was injected with simultaneous
recording of US signals on the B and M modes. Once IA positioning of the
needle was considered adequate, HA was injected and lateral radiographs
were taken 10 minutes later. Successful injections were conﬁrmed by a
sharply deﬁned shadow of air on the radiograph. A research nurse who was
blind to the objectives of the study asked the participants to assess the VAS
during injection, after each injection.
Results: The accuracy rates through I approach (78 out of 80, 97.5%)
were signiﬁcantly higher than those through Q approach (70 out of 80,
87.5%), (P=0.032). However, the VAS during injection through the Q ap-
proach (31.8±21.1%) was signiﬁcantly lower those through the I approach
(39.1±20.2%), (P=0.028).
Conclusions: In the Q approach, the straight surface of the US probe was
not ﬁt to the arc surface of thigh and the direction of the needle at the
insert site was unclear, so the accuracy rates were lower, compared with
those of the I approach. In the I approach, the needle punctured through
retinaculum tissue to reach the IA space and thus the VAS during the
injection was higher, compared with those of the Q approach.
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Purpose: Viscosupplementation is recognised as a valid treatment for
osteoarthritis and long-term results of hyaluronic acid inﬁltration therapy
reported in literature have encouraged the drug’s ever greater use in a
growing number of joints. The aim of our study was to determine the
eﬃcacy and safety of viscosupplementation with synthetic hyaluronic acid
to the hip joint.
